Caribou Biosciences, Inc. Gain (Loss) on Disposition of Assets
Caribou Biosciences, Inc. (CRBU) reported Gain (Loss) on Disposition of Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-13
- Caribou Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Caribou Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $0.00.
- Caribou Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2024-12-31 was $13.00K.
- Caribou Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2024-09-30 was -$4.00K.
- Caribou Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2025 was $25.00K, a 177.78% increase from fiscal 2024.
- Caribou Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2024 was $9.00K, a 73.53% decline from fiscal 2023.
- Caribou Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2023 was $34.00K.
- Caribou Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $25.00K 10-K · filed 2026-03-05 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $25.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $25.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $9.00K derived: sum of 2 quarters · filed 2026-03-05 | $9.00K derived: sum of 3 quarters · filed 2026-03-05 | $9.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$4.00K derived: sum of 2 quarters · filed 2025-11-12 | -$4.00K 10-Q · filed 2025-11-12 | -$4.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $0.00 derived: sum of 3 quarters · filed 2025-08-12 | $0.00 derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-03-10 | $0.00 derived: sum of 3 quarters · filed 2025-03-10 | $0.00 derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $0.00 derived: sum of 2 quarters · filed 2025-03-10 | $0.00 derived: sum of 3 quarters · filed 2025-03-10 | $34.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $34.00K 10-Q · filed 2024-11-06 | $34.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $34.00K 10-Q · filed 2024-08-06 | $34.00K derived: sum of 3 quarters · filed 2024-08-06 | $34.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $34.00K 10-Q · filed 2024-05-07 | $34.00K derived: sum of 2 quarters · filed 2024-05-07 | $34.00K derived: sum of 3 quarters · filed 2024-05-07 | $34.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $0.00 derived: sum of 2 quarters · filed 2024-03-11 | $0.00 derived: sum of 3 quarters · filed 2024-03-11 | $0.00 10-K · filed 2024-03-11 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | -$1.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | -$1.00K derived: sum of 3 quarters · filed 2023-08-08 | -$1.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | -$1.00K derived: sum of 2 quarters · filed 2023-05-09 | -$1.00K derived: sum of 3 quarters · filed 2023-05-09 | -$1.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$1.00K derived: sum of 2 quarters · filed 2023-03-09 | -$1.00K derived: sum of 3 quarters · filed 2023-03-09 | -$4.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | -$3.00K 10-Q · filed 2022-11-08 | -$3.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$3.00K 10-Q · filed 2022-08-09 | -$3.00K derived: sum of 3 quarters · filed 2022-08-09 | -$73.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$3.00K 10-Q · filed 2022-05-09 | -$3.00K derived: sum of 2 quarters · filed 2022-05-09 | -$73.00K derived: sum of 3 quarters · filed 2022-05-09 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$70.00K derived: sum of 2 quarters · filed 2022-03-21 | -$70.00K 10-K · filed 2022-03-21 | |
| 2020-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$70.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-09-02 | |||
| 2019-12-31 | -$1.00K 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |